In this study, they achieved read-through in skin-disorder (xeroderma pigmentosum complementation group C, XPC) patient-derived fibroblasts expressing the XPC gene with a nonsense mutation (1840C > T, Arg579X). The gene discussed is XPC; the disease is Xeroderma pigmentosum complementation group C.